儿童型滤泡淋巴瘤9例病理与临床分析
回顾性分析河南省肿瘤医院2017年2月至2023年2月收治的9例儿童型滤泡淋巴瘤(PTFL)患儿资料。9例均为男童,发病年龄6~18岁,临床表现为头颈部局部无痛性淋巴结肿大,分期Ⅰ~Ⅱ期,以局部手术切除为主,随访45~72个月全部存活且无复发。
要点
- PTFL多见于青少年男性,表现为头颈部无痛性淋巴结肿大,分期早。
- 病理呈高级别组织学、高Ki-67(70%~95%),Bcl-2阴性且缺乏t(14;18)易位。
- 以局部手术切除为主,本组随访45~72个月全部完全缓解无复发。
核心结论
- PTFL以青少年男性为主,病理呈高级别组织学和高增殖指数,缺乏t(14;18)、Bcl-2易位及Bcl-2表达。
- 以局部手术切除治疗为主,预后良好。
研究设计与样本
- 回顾性分析2017年2月至2023年2月河南省肿瘤医院收治的9例PTFL患儿的病理、临床特征、治疗方法及随访结果。
主要发现
- 9例患儿发病年龄6~18岁,均为男童,临床均表现为头颈部局部无痛性淋巴结肿大,临床分期Ⅰ~Ⅱ期。
- 组织形态学与经典型滤泡淋巴瘤相似,大部分滤泡生发中心扩大、套区消失、中心母细胞易见,组织学分级多为Ⅲ级,可伴「星空」现象。
- 免疫组织化学示CD20、CD10、Bcl-6阳性,Bcl-2、C-myc阴性,Ki-67为70%~95%。
- 荧光原位杂交检测t(14,18)阴性,Bcl-2易位、C-myc易位阴性。
- 6例单纯手术切除,3例手术切除联合化疗;截至2023年2月随访45~72个月,所有患儿均存活、无一例复发、均处于完全缓解状态。
关键数值与推荐
- PTFL免疫表型:CD20阳性、CD10阳性、Bcl-6阳性、Bcl-2阴性、C-myc阴性。
- PTFL增殖指数:Ki-67为70%~95%。
- PTFL遗传学:荧光原位杂交检测t(14,18)阴性,Bcl-2易位、C-myc易位阴性。
临床怎么用
- 对青少年男性头颈部无痛性淋巴结肿大,应结合病理形态、免疫表型及FISH检测t(14;18)和Bcl-2表达鉴别PTFL。
- PTFL以局部手术切除为主要治疗方式,部分病例可联合化疗,本组随访均完全缓解无复发。
局限性
- 本研究为单中心回顾性分析,样本量仅9例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To summarize the pathological diagnosis, clinical features, treatment methods and outcomes of pediatric-type follicular lymphoma (PTFL). Methods: Clinical data including the pathology, clinical features, treatment methods, and follow-up results of 9 PTFL patients admitted to Henan Cancer Hospital from February 2017 to February 2023 were analyzed retrospectively. Results: The age of onset in 9 children was 6 to 18 years, all the patients were males. The clinical manifestation was local painless lymph node enlargement in the head and neck, with a stage of Ⅰ-Ⅱ. The histomorphological characteristics of PTFL were similar to those of classic follicular lymphoma (FL). The germinal center of most follicles were enlarged, the mantle zone disappeared, centroblasts were easily visible, and the histological grade were mostly grade Ⅲ, which may be accompanied by the "starry sky" phenomenon. Monoclonal peaks can be seen in B cell clonal rearrangements (BCR). Immunohistochemistry (IHC) showed CD20 positive, CD10 positive, Bcl-6 positive, Bcl-2 negative, C-myc negative, and Ki-67 was 70%-95%. Fluorescence in situ hybridization (FISH) test was negative for t (14, 18), Bcl-2 translocation, and C-myc translocation. Six cases underwent surgical resection, and 3 cases underwent surgical resection combined with chemotherapy. Up to February 2023, with a follow-up time of 45 to 72 months, all children survived without any recurrence and were in a complete remission state. Conclusions: PTFL is mainly characterized by adolescent male onset, with early clinical manifestations and pathological manifestations of high-level histological status, high proliferation index, and lack of t (14; 18)/Bcl-2 translocation and Bcl-2 expression. It is mainly treated by localized surgical excision and has a good prognosis. 目的: 总结分析儿童型滤泡淋巴瘤(PTFL)的病理诊断、临床特征、治疗方法及转归。 方法: 回顾性总结2017年2月至2023年2月河南省肿瘤医院收治的9例PTFL患儿的临床资料,分析其病理、临床特征、治疗方法及随访结果。 结果: 9例患儿发病年龄为6~18岁,均为男童。临床均表现为头颈部局部无痛性淋巴结肿大,临床分期为Ⅰ~Ⅱ期。PTFL组织形态学特征与经典型的滤泡淋巴瘤(FL)相似,大部分滤泡生发中心扩大,套区消失,中心母细胞易见,组织学分级多为Ⅲ级,可伴“星空”现象。B细胞克隆性重排(BCR)可见单克隆峰。免疫组织化学(IHC)染色示CD20、CD10、Bcl-6阳性,Bcl-2、C-myc阴性,Ki-67为70%~95%。荧光原位杂交(FISH)检测t(14,18)阴性,Bcl-2易位、C-myc易位阴性。6例单纯手术切除,3例手术切除联合化疗。截至2023年2月,随访时间45~72个月,所有患儿均存活,无一例复发,均处于完全缓解状态。 结论: PTFL主要以青少年男性发病为主,病理表现为组织学高级别状态,高增殖指数,缺乏t(14;18)、Bcl-2易位及Bcl-2表达。以局部手术切除治疗为主,预后良好。.
引用
- Li GP, Zhang D, Wang YQ, et al. [Analysis of 9 cases of pediatric-type follicular lymphoma]. Zhonghua Er Ke Za Zhi. 2023. PMID: 38018051. doi:10.3760/cma.j.cn112140-20230710-00002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。